OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENT (IN EACH TABLET)
Acetaminophen 325mg
ACETAMINOPHEN
- Manufacturer
- TARGET CORPORATION | TIME CAP LABORATORIES, INC | TIME CAP LABORATORIES, INC.
- Effective date
- 2019-09-13
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:47:13
Label at a glance#
ProductACETAMINOPHEN
Active ingredientACETAMINOPHEN
Label structure8 sections
Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
povidone, pregelatinized starch, sodium starch glycolate*, stearic acid
*may contain this ingredient
OTC - PURPOSE SECTION
Purpose
Pain reliever/fever reducer
INDICATIONS & USAGE SECTION
Uses
temporarily relieves minor aches and pains due to:
the common cold
headache
backache
minor pain of arthritis
toothache
muscular aches
premenstrual and menstrual cramps
temporarily reduces fever
DOSAGE & ADMINISTRATION SECTION
DOSAGE & ADMINISTRATION
Directions
do not take more than directed (see overdose warning)
adults and children 12 years and over
take 2 tablets (1,000 mg) every 6 hours while symptoms last
do not take more than 6 tablets (3,000 ng) in 24 hours, unless directed by a doctor
do not take for more than 10 days unless directed by a doctor
children under 12 years
do not use this adult extra strength product in children under 12 years of age; this will provide more than the recommended dose (overdose) of acetaminophen and may cause liver damage
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
In case of accidental overdose, get medical help or contact a Poison Control Center. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
WARNINGS SECTION
Liver warning: This product contains acetaminophen. Severe liver damage may occur if you take
•
more than 12 tablets in 24 hours
•
with other drugs containing acetaminophen
•
3 or more alcoholic drinks every day while using this product
Allergy alert: Acetaminophen may cause severe skin reactions. Symptoms may include:
•
skin reddening
•
blisters
•
rash
If a skin reaction occurs, stop use and seek medical help right away.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 11673-841-01 | 2025-02-15 | C162847 | 48780-1 | 2cef2736-a632-d83d-e063-dadaa90ab31f | 340R-TARGET - APAP 325 MG 11673-841 |
| 11673-841-01 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-a632-d83d-e063-dadaa90ab31f | 340R-TARGET - APAP 325 MG 11673-841 |
Products#
Every source-derived product name is available through these pages.
- ACETAMINOPHEN
- POVIDONE
- STEARIC ACID
- STARCH, CORN
- SODIUM STARCH GLYCOLATE TYPE A CORN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11673-841 | 11673-841-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| POVIDONE | FZ989GH94E | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
| STARCH, CORN | O8232NY3SJ | IACT |
| SODIUM STARCH GLYCOLATE TYPE A CORN | AG9B65PV6B | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2cfe20df-40ae-8ae4-e063-6394a90a0d10 | 8ed205d1-5fa4-c05c-e053-2a95a90ad631 | 2025-02-15 | Warnings | 8ed205d1-5fa4-c05c-e053-2a95a90ad631 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.